DGEFX
Price
$14.73
Change
+$0.10 (+0.68%)
Updated
Dec 11 closing price
Net Assets
486.11M
EPSIX
Price
$24.87
Change
+$0.12 (+0.48%)
Updated
Dec 11 closing price
Net Assets
849.79M
Interact to see
Advertisement

DGEFX vs EPSIX

Header iconDGEFX vs EPSIX Comparison
Open Charts DGEFX vs EPSIXBanner chart's image
Destinations Equity Income I
Price$14.73
Change+$0.10 (+0.68%)
VolumeN/A
Net Assets486.11M
NYLI Epoch Global Equity Yield Inv Class
Price$24.87
Change+$0.12 (+0.48%)
VolumeN/A
Net Assets849.79M
DGEFX vs EPSIX Comparison Chart in %
View a ticker or compare two or three
VS
DGEFX vs. EPSIX commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGEFX is a Buy and EPSIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
EPSIX has more cash in the bank: 850M vs. DGEFX (486M). DGEFX pays higher dividends than EPSIX: DGEFX (2.13) vs EPSIX (1.69). DGEFX was incepted earlier than EPSIX: DGEFX (9 years) vs EPSIX (16 years). EPSIX (1.18) is less costly to investors than DGEFX (1.07). DGEFX is a more actively managed with annual turnover of: 45.00 vs. EPSIX (18.00). DGEFX has a lower initial minimum investment than EPSIX: DGEFX (0) vs EPSIX (2500). DGEFX annual gain was more profitable for investors over the last year : 16.53 vs. EPSIX (12.47). DGEFX return over 5 years is better than : 66.09 vs. EPSIX (54.76).
DGEFXEPSIXDGEFX / EPSIX
Total Expense Ratio0.941.1780%
Annual Report Gross Expense Ratio1.071.1891%
Fund Existence9 years16 years-
Gain YTD19.41715.334127%
Front LoadN/A5%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets486M850M57%
Annual Yield % from dividends2.131.69126%
Returns for 1 year16.5312.47133%
Returns for 3 years37.2035.95103%
Returns for 5 years66.0954.76121%
Returns for 10 yearsN/A73.50-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASND210.168.92
+4.43%
Ascendis Pharma A/S
CLLS5.220.09
+1.75%
Cellectis SA
TXG16.54-0.99
-5.65%
10x Genomics
PTIX1.58-0.10
-5.95%
Protagenic Therapeutics Inc
DHX1.58-0.12
-7.06%
DHI Group